ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 671

A New Histological Index for Predicting a Decline in Kidney Function in Patients with Lupus Nephritis. a Mexican Cohort Study of 186 Patients with a Kidney Biopsy

Marco Ulises Martinez-Martinez1, Cesar Eduardo Vallín Orozco2, David Martínez-Galla3 and Carlos Abud-Mendoza4, 1Unidad de Investigaciones Reumatológicas, Faculty of Medicine, Universidad Autónoma de San Luis Potosí and Hospital Central, San Luis Potosí, Mexico, 2Rheumatology, Hospital Central "Dr. Ignacio Morones Prieto", San Luis Potosí, Mexico, 3Pathology, Hospital Central "Dr. Ignacio Morones Prieto", San Luis Potosí, Mexico, 4Unidad de Investigaciones Reumatológicas y Osteoporosis, Faculty of Medicine, Universidad Autónoma de San Luis Potosí and Hospital Central, San Luis Potosí, Mexico

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Lupus nephritis, prognostic factors and systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 5, 2017

Title: Systemic Lupus Erythematosus – Clinical Aspects and Treatment Poster I: Biomarkers and Outcomes

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

–       Background/Purpose: The NIH indexes (of activity and chronicity) were proposed by Austin et al., in 1984. At the moment, there are therapies which can modify the histology of lupus nephritis; therefore, the markers of prognosis in the kidney biopsy may have different hazard ratios to the described by Austin et al.

–       Methods:  We evaluated all the patients in whom a kidney biopsy was performed. DKF was defined as a glomerular filtration rate (GFR) of ≤ 60 ml/min/m2 in two determinations in the follow-up.  Histology was graded from 0-3 for glomerular or tubular abnormalities weighted by the intensity of damage. Factors associated with the development of DKF according to the different factors were evaluated through Kaplan-Meier curves and multivariate Cox regression analysis. Cox regression analysis was used to evaluate independent factors associated with the development of DKF. Independent factors in the multivariate analysis were used to construct the new index using the hazard ratio of each variable. ROC curves for survival (Heagerty et al, 2000) were used to evaluate the performance of the new index in comparison with the activity and chronicity indexes.

–       Results: We have followed 186 patients with LN and kidney biopsy, 143 (76.9%) women, mean age at kidney biopsy was 29.7 ± 12.9 years; classes of LN were: 78 patients (41.3%) class IV, 31 (16.4%) class V, 23 (12.2%) class III/V, 23 (12.2%) class IV/V, 19 (10.1%) class III, and other classes 12 patients; 135 patients (79.5%) have a minimum follow-up of 12 months. Table 1 shows the results of the univariate and the final multivariate model that was used to develop the new index. ROC curves showed AUC for detecting DKF at 12 moths for activity, chronicity and our new index of 0.59, 0.70 and 0.74 respectively. Figure 1 shows the survival according two groups: low index (new index lower than the median) and high index.

Table1.

Histological feature

Univariate

HR (CI)

Univariate

p-value

Multivariate

HR (CI)

Multivariate

p-value

Glomerular abnormalities

Cellular proliferation

1.06 (0.88-1.28)

0.547

NA

NA

Karyorrhexis

0.94 (0.72-1.13)

0.364

NA

NA

Cellular crescents

1.09 (0.96-1.22)

0.364

NA

NA

Hyaline thrombi

0.91 (0.70-1.17)

0.453

NA

NA

Leukocyte infiltration

1.23 (0.97-1.57)

0.059

NA

NA

Glomerular sclerosis

1.64 (1.33-2.03)

< 0.001

1.48 (1.14-1.91)

0.003

Fibrous crescents

1.68 (1.27-2.21)

< 0.001

1.35 (0.99-1.82)

0.051

Tubulointerstitial abnormalities

Interstitial cell infiltration

1.34 (1.17-1.55)

< 0.001

1.41 (1.02-1.94)

0.038

Interstitial fibrosis

1.30 (0.97-1.75)

0.162

NA

NA

Tubular atrophy

1.35 (1.05-1.74)

0.025

NA*

NA*

* Tubular atrophy was no included in the final model.

–       Conclusion: We suggest predicting the risk of DKF with glomerular sclerosis, fibrous crescents, and interstitial cell infiltration. Maybe the other histological characteristics could be modified by the new therapies.

Figure 1.


Disclosure: M. U. Martinez-Martinez, None; C. E. Vallín Orozco, None; D. Martínez-Galla, None; C. Abud-Mendoza, None.

To cite this abstract in AMA style:

Martinez-Martinez MU, Vallín Orozco CE, Martínez-Galla D, Abud-Mendoza C. A New Histological Index for Predicting a Decline in Kidney Function in Patients with Lupus Nephritis. a Mexican Cohort Study of 186 Patients with a Kidney Biopsy [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/a-new-histological-index-for-predicting-a-decline-in-kidney-function-in-patients-with-lupus-nephritis-a-mexican-cohort-study-of-186-patients-with-a-kidney-biopsy/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a-new-histological-index-for-predicting-a-decline-in-kidney-function-in-patients-with-lupus-nephritis-a-mexican-cohort-study-of-186-patients-with-a-kidney-biopsy/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology